The Moat Index
Compare moats, side by side.
Two to four companies, scored on the same five investor questions from their SEC filings — so the comparison is apples to apples. The method is fully public.
BCDA · Healthcare · Shallow moat
Doesn't clear the bar
The returnsOnCapital component abstained: Not enough years of ROIC data to score returns on capital. The other four 20% weights were renormalized over the scored 80%.
| Measure | BCDA | XRAY | EBS | ATEC |
|---|---|---|---|---|
| Moat Score (0–100) | 45 (highest) | 45 (highest) | 45 (highest) | 45 (highest) |
| Methodology version | moat-index@2.0.0 | moat-index@2.0.0 | moat-index@2.0.0 | moat-index@2.0.0 |
| Business trend | 53 | 46 | 60 (highest) | 54 |
| Pricing power | 29 | 88 | 68 | 99 (highest) |
| Returns on capital | — | 0 | 11 (highest) | 0 |
| Balance-sheet safety | 55 (highest) | 28 | 29 | 28 |
| Capital discipline | 44 | 64 (highest) | 57 | 44 |
| Price vs. high estimate | No price data | No price data | No price data | No price data |
| Market cap | $9.7M | $2.7B | $400.6M | $1.2B |
| Moat tier | Shallow moat | Shallow moat | Shallow moat | Shallow moat |
| Filings as of | FY2025 | FY2025 | FY2025 | FY2025 |